Focusing instead on genes that are involved in energy absorption and that are associated with a “human starvation phenotype”, we have identified enteropeptidase (EP), a gene associated with congenital enteropeptidase deficiency, as a novel target for obesity treatment. The gene discussed is TMPRSS15; the disease is congenital enteropathy due to enteropeptidase deficiency.